| Literature DB >> 33986616 |
Abstract
OBJECTIVE: This study aims to establish whether there is a relationship between the level of knowledge about COVID-19, anxiety scores, and pseudo increases in the symptoms of the patients or not.Entities:
Keywords: COVID-19; anxiety; knowledge level; symptoms
Year: 2021 PMID: 33986616 PMCID: PMC8110269 DOI: 10.2147/PRBM.S307050
Source DB: PubMed Journal: Psychol Res Behav Manag ISSN: 1179-1578
The Questionnaire Used in the Study
| Questions | Answers |
|---|---|
| 1–21) The BAI | Not at all/Mildly/Moderately/Severely |
| 22) Incubation period | 0–1 days/2–14 days/15–21 days/Over 22 days/No idea |
| 23) Risk groups | Aged 65+ yearsComorbidity/Immunosuppressed patients/Healthcare workers/aged 0–19 years |
| 24) Main route of transmission | Droplet/Airborne/Direct contact/Oral/No idea |
| 25) Symptoms | Shortness of breath/High fever/Dry cough/Chest pain/Wet cough |
| 26) Prevention | Social distance/Mask/Airing out the house/Traditional cologne water/Alcohol based antiseptics/Disposable gloves |
| 27) Social distance | Less than 1 meter/At least 1.5 meters/More than 3 meters |
| 28) People who need to wear a mask | People with a sickness/People who might be sick/People who are in contact with sick people/Healthy people/Healthcare workers/Others |
| 29) Your risk of catching COVID-19 | 0–20%/21–40%/41–60%/61–80%/81–100% |
| 30) Symptoms you have had in last 3 months | Loss of smell/Loss of taste/Tinnitus/Vertigo/Loss of hearing/Headache/Dysphagia/Numbness and tingling in face/Others/None |
Note: The participants were able to choose more than one option for the 23rd, 25th, 26th, 28th, and 30th questions.
Responses for the Level of Knowledge About COVID-19 Questions
| Patients [n (%)] | |
|---|---|
| Incubation period | |
| 0–1 days | 16 (4.0) |
| 2–14 days | 369 (91.8) |
| 15–21 days | 6 (1.5) |
| Over 22 days | 6 (1.5) |
| No idea | 5 (1.2) |
| Risk groups | |
| Aged 65+ years | 381 (94.8) |
| Comorbidity | 287 (71.4) |
| Immunosuppressed patients | 241 (60.0) |
| Healthcare workers | 158 (39.3) |
| Aged 0–19 years | 83 (20.6) |
| Main route of transmission | |
| Droplet | 171 (42.5) |
| Airborne | 117 (29.1) |
| Direct contact | 92 (22.9) |
| Oral | 19 (4.7) |
| No idea | 3 (0.7) |
| Symptoms | |
| Shortness of breath | 378 (94.0) |
| High fever | 387 (96.3) |
| Dry cough | 328 (81.6) |
| Chest pain | 84 (20.9) |
| Wet cough | 27 (6.7) |
| Prevention | |
| Social distance | 382 (95.0) |
| Mask | 364 (90.5) |
| Airing out the house | 229 (57.0) |
| Traditional cologne water | 256 (63.7) |
| Alcohol based antiseptics | 187 (46.5) |
| Disposable gloves | 118 (29.4) |
| Social distance | |
| Less than 1 meter | 7 (1.74) |
| At least 1.5 meters | 379 (94.28) |
| More than 3 meters | 16 (3.98) |
| People who need to wear a mask | |
| People with a sickness | 379 (94.3) |
| People who might be sick | 350 (87.1) |
| People who are in contact with sick people | 352 (87.6) |
| Healthy people | 340 (84.6) |
| Healthcare workers | 351 (87.3) |
| Others | 53 (13.2) |
Responses for the Self-Assessed Infection Risk, and Symptoms Patients Showed in the Last 3 Months Questions
| Patients [n (%)] | |
|---|---|
| Your risk of catching COVID-19 | |
| 0–20% | 143 (35.6) |
| 21–40% | 126 (31.3) |
| 41–60% | 68 (16.9) |
| 61–80% | 30 (7.5) |
| 81–100% | 35 (8.7) |
| Symptoms you have had in last 3 months | |
| Loss of smell | 7 (1.7) |
| Loss of taste | 5 (1.2) |
| Tinnitus | 62 (15.4) |
| Vertigo | 111 (27.6) |
| Loss of hearing | 123 (30.6) |
| Headache | 57 (14.2) |
| Dysphagia | 14 (3.5) |
| Numbness and tingling in face | 4 (1) |
| Others | 55 (11.7) |
| None | 136 (33.8) |
The Pearson Correlation Analysis
| 1 | 2 | 3 | 4 | |
|---|---|---|---|---|
| 1. Anxiety scores | – | |||
| 2. Information levels | –0.051 | – | ||
| 3. Risk of infection | 0.679* | –0.124 | – | |
| 4. Symptoms | 0.627* | –0.089 | 0.548* | – |
Note: *Correlation is significant at the 0.001 level (2-tailed).